Earnings Call · Q3 FY2022·2022-11-03

Q3 22EPS -18.65%·Rev n/aQ2 22EPS +16.70%·Rev n/aQ1 22EPS +52.67%·Rev n/aQ4 21EPS +14.04%·Rev n/a⚠ consensus missing

Moderna, Inc. MRNA

Lavina Talukdar — Head of Investor Relations

Stéphane Bancel — Chief Executive Officer

Stephen Hoge — President

Arpa Garay — Chief Commercial Officer

Jamey Mock — Chief Financial Officer

−0.8%1d on move date+0.3% vs SPY3d+10.4%5d+9.8%

Research tier

Behavioral profile computed for 5 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more MRNA calls or request research access.

More MRNA calls Browse calls Request research access